SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Yochi Slonim / Anima Biotech CEO
Business
Anima Biotech and Takeda Enter Collab to Target mRNA Translation with Small Molecules
Anima Biotech’s strategic collaboration with Takeda Pharmaceutical, just announced today, uses its novel platform for discovery of mRNA translation modulators to discover and develop a new class of therapies for neurological diseases.
March 18, 2021
 · 
5 min read
 · 
Gail Dutton
Jeremy Levin, chairman of the global Biotechnology
Policy
The Race to a COVID-19 Vaccine Ignites a Cold War-Type Era with Russia
The COVID-19 pandemic is not only an international health crisis, but a burgeoning geopolitical exercise for Russia to win the hearts and minds of a large portion of the world while undermining the West.
March 16, 2021
 · 
4 min read
 · 
Gail Dutton
CRISPR Screening IDs Host Factors Essential for Coronavirus Entry into Cells
Identifying the common host factors that are essential for coronavirus replication is an important element in developing broad-spectrum, antiviral therapeutics.
March 16, 2021
 · 
5 min read
 · 
Gail Dutton
FDA
At-Home, Prescription-free COVID-19 Dx Tests Enter the Real Marketplace: Amazon
EmpowerDX, a Eurofins subsidiary, just launched its direct-to-consumer COVID-19 Home Collection Kit in the U.S. through Amazon, making it one of a miniscule number of at-home and over-the-counter kits that are putting detection of the SARS-CoV-2 virus in the hands of patients.
March 15, 2021
 · 
3 min read
 · 
Gail Dutton
Drug Development
Endemic COVID-19 Needs Novel, Prognostic Tests to Predict Severity and Progression
Some diagnostic developers are looking ahead to the time when COVID-19 is endemic throughout the population and most people are vaccinated. From a public health perspective, COVID-19 will be treated like the seasonal flu.
March 12, 2021
 · 
4 min read
 · 
Gail Dutton
2020 Tailwinds Usher in a Post-Pandemic Biotech Revolution
Cooperation and collaboration accelerated drug development timelines during the pandemic, and those gains are expected to continue into the coming years. Innovation is increasing too, as new tools are developed.
March 10, 2021
 · 
4 min read
 · 
Gail Dutton
Genetown
New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought
A drug to halt the progression of Alzheimer’s disease will likely be approved within the next three years, and Alzheon’s ALZ-801 might be the leading candidate.
March 9, 2021
 · 
5 min read
 · 
Gail Dutton
BDO Predicts Strong 2021 Biotech Economy, Alongside US Economic Rebound
Biotech is poised to benefit. The industry is coming off a record year for biotech IPOs in terms of numbers of deals, as well as their proceeds.
March 4, 2021
 · 
3 min read
 · 
Gail Dutton
Determining Value is as Critical to Commercial Success as Clinical Data
The shifting focus from drug pricing to drug value is having a significant effect on innovation, performance and even investments.
March 2, 2021
 · 
5 min read
 · 
Gail Dutton
Business
Field Trip Health’s New Psilocybin Research Facility Probes the Secrets of Shrooms
The world’s first legal research and cultivation facility dedicated exclusively to psilocybin-producing mushrooms (called shrooms or magic mushrooms) and other plant-based psychedelics recently opened in Jamaica.
February 26, 2021
 · 
4 min read
 · 
Gail Dutton
10x Genomics Announces New Product Lineup and Tetramer Shop Acquisition
10x Genomics, Inc. introduced its 2021-2022 product lineup during Xperience 2021, a special presentation Wednesday with an audience of nearly 2,700.
February 25, 2021
 · 
4 min read
 · 
Gail Dutton
BioCapital
FBRI’s IT Upgrades Boost Research Capabilities, Laying Foundation for 2x Capacity
The Fralin Biomedical Research Institute (FBRI) at Virginia Tech Carilion (VTC) replaced its information technology (IT) system as one of the foundational steps that, within the next few years, will allow the research center to double its research capacity with the addition of more than 25 new labs.
February 24, 2021
 · 
4 min read
 · 
Gail Dutton
Policy
LightDeck Diagnostics Gets $5.65 Million for Rapid, Portable SARS-CoV-2 Antigen Test
The funding, provided by the Biomedical Advanced Research and Development Authority at the Department of Health and Human Services, is enough to advance the test to commercialization.
February 22, 2021
 · 
4 min read
 · 
Gail Dutton
lucarista/Shutterstock
Job Trends
Novartis’ CAR T Reimbursement Strategy Finds Sweet Spot Between Value and Price
Novartis managed to bridge the gap between evidence of efficacy and value in this space with a variety of value-based pricing plans developed with regional payers.
February 19, 2021
 · 
5 min read
 · 
Gail Dutton
Project Farma: Manufacturing Skills Gap Creates Bottleneck for Cell and Gene Therapy
The skills gap in cell and gene therapy is creating a bottleneck that is slowing the abilities of innovative therapies to reach patients, delaying manufacturing scaleup and increasing learning and development costs.
February 18, 2021
 · 
5 min read
 · 
Gail Dutton
Load More